Axa Portfolio holdings
AUM
$34.8B
1-Year Return
21.93%
This Quarter Return
+8.97%
1 Year Return
+21.93%
3 Year Return
+101.72%
5 Year Return
+168.92%
10 Year Return
+430.37%
AUM
$35.5B
AUM Growth
+$2.63B
(+8%)
Cap. Flow
-$384M
Cap. Flow
% of AUM
-1.08%
Top 10 Holdings %
Top 10 Hldgs %
19.61%
Holding
1,343
New
136
Increased
426
Reduced
527
Closed
93
Top Buys
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$78M |
| 2 |
Stellantis
STLA
|
+$67.3M |
| 3 |
Apple
AAPL
|
+$59.7M |
| 4 |
Cincinnati Financial
CINF
|
+$37M |
| 5 |
Visa
V
|
+$33.8M |
Top Sells
| 1 |
PFPT
Proofpoint, Inc.
PFPT
|
+$130M |
| 2 |
EPAM Systems
EPAM
|
+$71.2M |
| 3 |
NVIDIA
NVDA
|
+$58.9M |
| 4 |
Applied Materials
AMAT
|
+$49.4M |
| 5 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
+$47.4M |
Sector Composition
| 1 | Technology | 30.04% |
| 2 | Healthcare | 16.84% |
| 3 | Consumer Discretionary | 12.32% |
| 4 | Financials | 10.53% |
| 5 | Industrials | 8.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
626
Upbound Group
UPBD
$1.47B
| $6.15M | 0.02% |
115,900
-13,000
| -10% | -$690K |
|
627
RH
RH
$4.36B
| $6.11M | 0.02% |
+9,000
| New | +$6.11M |
|
628
Qiagen
QGEN
$10.2B
| $6.07M | 0.02% |
118,265
-12,846
| -10% | -$659K |
|
629
Ross Stores
ROST
$49.6B
| $6.04M | 0.02% |
48,663
-691
| -1% | -$85.7K |
|
630
Owens & Minor
OMI
$416M
| $6M | 0.02% |
141,700
-41,300
| -23% | -$1.75M |
|
|
BCYC
631
Bicycle Therapeutics
BCYC
$485M
| $6M | 0.02% |
197,510
-289
| -0.1% | -$8.77K |
|
632
Intellia Therapeutics
NTLA
$1.28B
| $5.99M | 0.02% |
+36,986
| New | +$5.99M |
|
633
Hormel Foods
HRL
$14B
| $5.97M | 0.02% |
124,998
+87,086
| +230% | +$4.16M |
|
634
TechnipFMC
FTI
$16.1B
| $5.95M | 0.02% |
657,680
+311,189
| +90% | +$2.82M |
|
635
Medifast
MED
$152M
| $5.94M | 0.02% |
21,000
-2,900
| -12% | -$821K |
|
636
A.O. Smith
AOS
$10.4B
| $5.94M | 0.02% |
82,400
-99,700
| -55% | -$7.18M |
|
637
Weibo
WB
$3B
| $5.91M | 0.02% |
112,300
+2,300
| +2% | +$121K |
|
638
Travelers Companies
TRV
$61.8B
| $5.87M | 0.02% |
39,235
-15,308
| -28% | -$2.29M |
|
639
ALX Oncology
ALXO
$59.4M
| $5.82M | 0.02% |
106,422
+11,724
| +12% | +$641K |
|
|
NGM
640
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $5.77M | 0.02% |
+292,441
| New | +$5.77M |
|
|
SYKE
641
DELISTED
SYKES Enterprises Inc
SYKE
| $5.75M | 0.02% |
107,000
-32,900
| -24% | -$1.77M |
|
642
NetApp
NTAP
$24.2B
| $5.74M | 0.02% |
70,111
+48,239
| +221% | +$3.95M |
|
643
Vipshop
VIPS
$8.72B
| $5.73M | 0.02% |
285,522
-358,000
| -56% | -$7.19M |
|
644
FTI Consulting
FCN
$5.41B
| $5.66M | 0.02% |
41,400
+24,000
| +138% | +$3.28M |
|
645
Ingredion
INGR
$8.22B
| $5.66M | 0.02% |
62,491
-11,400
| -15% | -$1.03M |
|
646
Innovative Industrial Properties
IIPR
$1.59B
| $5.65M | 0.02% |
29,600
+10,900
| +58% | +$2.08M |
|
647
East-West Bancorp
EWBC
$15.1B
| $5.61M | 0.02% |
78,300
-19,100
| -20% | -$1.37M |
|
648
MKS Inc. Common Stock
MKSI
$7.32B
| $5.61M | 0.02% |
31,500
-22,900
| -42% | -$4.07M |
|
649
Brinker International
EAT
$6.93B
| $5.59M | 0.02% |
90,300
+87,400
| +3,014% | +$5.41M |
|
650
Ironwood Pharmaceuticals
IRWD
$184M
| $5.57M | 0.02% |
+432,900
| New | +$5.57M |
|